Clinical Trials in Tennessee

Showing 10701-10720 of 20,239 trials

Esophageal Monitoring Device for Assessing Mucosal Impedance

NCT01556919

The investigators are looking at a novel approach to measuring gastroesophageal reflux disease (GERD) damage and reducing the need for costly and less optimal testing presently used for diagnostic and treatment purposes. The investigators will be using three custom mucosal impedance (MI) catheters, each designed to measure at slightly different spacing on the esophagus.

GERDEsophagitis

Vanderbilt University429 participantsStarted Mar 2012

Nashville, Tennessee, United States

COMPLETEDPhase 129 miles

Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor

NCT01123876

Assess whether the combination of ABT-888 with FOLFIRI has activity in subjects with gastric cancer.

Gastric Cancer

AbbVie (prior sponsor, Abbott)60 participantsStarted Mar 2010

Scottsdale, Arizona, United States • Los Angeles, California, United States • Los Angeles, California, United States +5 more locations

TERMINATEDPhase 329 miles

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01

NCT03285308

This study will evaluate the safety and efficacy of relamorelin compared to placebo in participants with diabetic gastroparesis. Participants will report daily severity scores of their diabetic gastroparesis symptoms.

GastroparesisDiabetes Mellitus

Allergan336 participantsStarted Sep 2017

Birmingham, Alabama, United States • Dothan, Alabama, United States • Huntsville, Alabama, United States +213 more locations

Esophageal Monitoring Device for Assessing Mucosal Impedance

Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01

Find Trials by Condition in Tennessee

IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Registry of Subject Treated With ClariFix

Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC

Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC

Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART)

Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma

A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone

Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis

A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis

Role of Rehabilitation in Concussion Management: A Randomized Controlled Trial

This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors

A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-Dependent Beta Thalassemia

Preventing Excessive Gestational Weight Gain in Obese Women